Cashu | News | ARGX

HomeWatchlistNewsSignalsPicks

DJI

-0.20%

SPX

-0.64%

IXIC

-1.15%

FTSE

-0.32%

N225

-0.26%

AXJO

-0.08%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Argen X SE News

Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win

Feature Image for interests on Analyst Color, Biotech, Expert Ideas, Healthcare from benzinga.com

Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data

Feature Image for interests on Biotech, Health Care, Healthcare, Iran from benzinga.com

Assessing argenx: Insights From 11 Financial Analysts

Where argenx Stands With Analysts

FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls

Feature Image for interests on Biotech, Briefs, Healthcare, Large Cap from benzinga.com

With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around?

Feature Image for interests on Analyst Color, Analyst Ratings, Argx, Benzinga from benzinga.com

finance.yahoo.com

Here’s Why argenx SE (ARGX) Rose 9% in Q2

Feature Image for interests on Healthcare, Investment Management Company, Investor Letter, Mid Cap Growth Strategy from finance.yahoo.com

finance.yahoo.com

Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB

Feature Image for interests on Biologics License Application, Fda, Healthcare, Investigational Treatment from finance.yahoo.com

about 1 year ago

argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024

about 1 year ago

finance.yahoo.com

What Made argenx SE (ARGX) Rise in Q2?

Feature Image for interests on Artisan Partners, Biotechnology Company, Financial Services, Healthcare from finance.yahoo.com

about 1 year ago

Stocks

Health Care

argx

Argen X SE

NYSE EURONEXT - EURONEXT BRUSSELS: ARGX

+8.31 (+1.18%)

712.38

USD

At close at Aug 29, 20:42 UTC

Latest Cashu News

Argenx SE (ARGX) Reports Positive Vyvgart Trial Results for Autoimmune Treatment in gMG

about 13 hours ago

Argenx SE: Analyst Sentiment Highlights Opportunities and Challenges in Biotechnology Sector

Argenx SE (ARGX): Analyst Opinions Highlight Mixed Outlook in Biotechnology Sector